CN102520113B - Detection method for fifteen Rupeng preparation - Google Patents

Detection method for fifteen Rupeng preparation Download PDF

Info

Publication number
CN102520113B
CN102520113B CN201110427293.8A CN201110427293A CN102520113B CN 102520113 B CN102520113 B CN 102520113B CN 201110427293 A CN201110427293 A CN 201110427293A CN 102520113 B CN102520113 B CN 102520113B
Authority
CN
China
Prior art keywords
solution
thin
medicinal material
control medicinal
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201110427293.8A
Other languages
Chinese (zh)
Other versions
CN102520113A (en
Inventor
李波
陈丽娟
张国霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tibet Cheezheng Tibetan Medicine Co Ltd
Original Assignee
Tibet Cheezheng Tibetan Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibet Cheezheng Tibetan Medicine Co Ltd filed Critical Tibet Cheezheng Tibetan Medicine Co Ltd
Priority to CN201110427293.8A priority Critical patent/CN102520113B/en
Publication of CN102520113A publication Critical patent/CN102520113A/en
Application granted granted Critical
Publication of CN102520113B publication Critical patent/CN102520113B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to a detection method for a fifteen Rupeng preparation. The detection method comprises one or several of detection of Common Vladimiria Root, Semen Cassiae and Rhizoma Acori Calami in the preparation through thin layer chromatography, and detection of the content of aconitine in the preparation.

Description

The detection method of ten five tastes breast roc preparations
Technical field
The invention belongs to technical field of traditional Chinese medicines, be specifically related to a kind of detection method of Chinese medicine preparation.
Background technology
Ten five tastes breast roc balls are Tibetan medicine's tradition proved recipes, and prescription is comprised of shellfish main officer of Tibet, wide muscle rattan, cassia seed, the tame and docile cream of slag, Semen seu folium abelmoschi moschati, Rhizoma Acori Calami, BAXIAGA, catechu, myrobalan's (stoning), styrax, terminaliae billericae,fructus, Aconitum Szechenyianum Gay (system), the banksia rose, emblic, Moschus ten gomi herbs.Can anti-inflammatory analgetic, dry yellow water, for joint congestion and swelling pain, itches, gout, yellow water gathers.
Ten five tastes breast roc balls that use are at present recorded in first of < < Drug Standard of Ministry of Public Health of the Peoples Republic of China nineteen ninety-five version Tibetan medicine:
Tibetan medicine name: Bi Qiong Ai Bu of a specified duration
Phonetic name: Shiwuwei Rupeng Wan
Book page number: C1-199 standard number: WS3-BC-0196-95
[prescription] shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax 60g, terminaliae billericae,fructus 150g, Aconitum Szechenyianum Gay 75g, banksia rose 150g, Moschus 1.5g, emblic 150g.
[method for making] above ten five tastes, slagging-off is tamed and dociled outside cream, Moschus, and all the other are ground into fine powder, sieve, and add muscone's fine powder, mix, and tame and docile cream add appropriate water pill with slag, dry in the shade and get final product.
[proterties] this product is the sepia water-bindered pill; The micro-perfume (or spice) of gas, bitter.
[inspection] should meet every regulation relevant under pill item (8 pages of appendix).
[function with cure mainly] anti-inflammatory analgetic, dry yellow water.For joint congestion and swelling pain, itch, gout, yellow water gathers.
[usage and consumption] 2~4 balls, 2 times on the one.
The heavy 3g of [specification] every 10 balls.
[storage] is airtight, puts shady and cool dry place
Not yet there is at present the detection method of ten five tastes breast roc preparations, also do not have toxic component in the other side to carry out the method for content detection.
Summary of the invention
The object of the present invention is to provide a kind of detection method of ten five tastes breasts roc preparations, described detection method has that specificity is strong, favorable reproducibility, the advantage such as easy and simple to handle.
For achieving the above object, technical scheme of the present invention is:
A detection method for ten five tastes breast roc preparations, said preparation bulk drug consists of: frankincense 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g; The method comprises one or more of following discriminating and/or inspection method: cross thin-layer chromatography the radix jurineae in preparation, cassia seed, Rhizoma Acori Calami are carried out to qualitative discriminating, and check preparation mesaconitine content.
Particularly, the qualitative discriminating of radix jurineae comprises:
1a) prepare radix jurineae need testing solution, radix jurineae control medicinal material solution, not containing the negative sample solution of radix jurineae;
2a), according to 2010 editions one appendix VI B of thin-layered chromatography < < Chinese Pharmacopoeia > > test, draw respectively step 1a) need testing solution, control medicinal material solution, negative sample solution the point sample that obtain be on same silica gel g thin-layer plate;
3a) take cyclohexane-methylene chloride-ethyl acetate as developping agent, by step 2a) thin layer plate that obtains be placed on saturated in expansion cylinder, launch, take out, dry, spray is with vanillic aldehyde sulfuric acid solution, it is clear that hot blast blows to spot colour developing, in thin-layer chromatography, with the corresponding position of radix jurineae control medicinal material chromatogram on, the spot of the aobvious same color of test sample chromatogram;
The qualitative discriminating of cassia seed comprises:
1b) prepare cassia seed need testing solution, cassia seed control medicinal material solution, not containing the negative sample solution of cassia seed;
2b), according to 2010 editions one appendix VI B of thin-layered chromatography < < Chinese Pharmacopoeia > > test, draw respectively step 1b) need testing solution, control medicinal material solution, negative sample solution the point sample that obtain be on same silica gel g thin-layer plate;
3b) take the upper strata liquid of sherwood oil-ethyl formate-formic acid as developping agent, by step 2b) thin layer plate that obtains be placed on saturated in expansion cylinder, launch, take out, dry, under ultraviolet lamp, inspect, in thin-layer chromatography, with the corresponding position of cassia seed control medicinal material chromatogram on, the fluorescence spot of the aobvious same color of test sample chromatogram;
The qualitative discriminating of Rhizoma Acori Calami comprises:
1c) prepare Rhizoma Acori Calami need testing solution, Rhizoma Acori Calami control medicinal material solution, not containing the negative sample solution of Rhizoma Acori Calami;
2c), according to 2010 editions one appendix VI B of thin-layered chromatography < < Chinese Pharmacopoeia > > test, draw respectively rapid 1c) need testing solution, control medicinal material solution, negative sample solution the point sample that obtain be in same silica G F 254on thin layer plate;
3c) take petroleum ether-ethyl acetate as developping agent, by step 2c) thin layer plate that obtains be placed on saturated in expansion cylinder, launch, take out, dry, under ultraviolet lamp, inspect; In thin-layer chromatography, with the corresponding position of Rhizoma Acori Calami control medicinal material chromatogram on, the blackening point of the aobvious same color of test sample chromatogram;
Content of Aconitine inspection comprises:
1d) prepare aconitine need testing solution, aconitine reference substance solution;
2d) according to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, draw respectively step 1d) need testing solution that obtains, aconitine reference substance solution point sample are on same silica gel g thin-layer plate;
3d) take cyclohexane-ethyl acetate-diethylamine as developping agent, by step 2d) thin layer plate that obtains be placed on saturated in expansion cylinder, launch, take out, dry, spray is with rare bismuth potassium iodide test solution, in thin-layer chromatography, test sample chromatogram with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
The preparation method of the need testing solution of described radix jurineae, cassia seed, Rhizoma Acori Calami and aconitine, control medicinal material solution, negative sample solution comprises:
(1) radix jurineae
Get described ten five tastes breast roc preparations, porphyrize, adds acetone, and ultrasonic processing filters, and filtrate is concentrated, as the need testing solution of radix jurineae; Separately get radix jurineae control medicinal material, be made in the same way of radix jurineae control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution;
(2) cassia seed
Get described ten five tastes breast roc preparations, porphyrize, adds methyl alcohol, adds hot reflux, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution, ultrasonic processing, then add methenyl choloride, add hot reflux, cooling, in dislocation separating funnel, divide and get methenyl choloride layer, acid solution is extracted with methenyl choloride, adds anhydrous sodium sulfate and dewaters in right amount, filters, filtrate volatilizes, and residue adds methyl alcohol to be made to dissolve, as the need testing solution of cassia seed; Separately depend on pine torch control medicinal material, be made in the same way of cassia seed control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution;
(3) Rhizoma Acori Calami
Get described ten five tastes breast roc preparations, add methyl alcohol, ultrasonic, filter, filtrate is concentrated, as the need testing solution of Rhizoma Acori Calami; Separately get Rhizoma Acori Calami control medicinal material, be made in the same way of Rhizoma Acori Calami control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution;
(4) aconitine
Get described ten five tastes breast roc preparations, porphyrize, adds ammonia solution, stirs evenly, and places, and adds diethyl ether, and jolting, places, filter, and filtrate evaporate to dryness, residue adds absolute ethyl alcohol to be made to dissolve, the need testing solution detecting as Content of Aconitine; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make solution, as aconitine reference substance solution.
Preferably, said method comprising the steps of:
A) the qualitative discriminating of radix jurineae
Get described ten five tastes breast roc preparation 1~3 weight portions, porphyrize, adds acetone 10~30 parts by volume, and ultrasonic processing 10~30 minutes filters, and filtrate concentrates approximately 1~3 parts by volume, as the need testing solution of radix jurineae; Separately get radix jurineae control medicinal material 0.1~0.8 weight portion, be made in the same way of radix jurineae control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution; According to 2010 editions appendix VIB tests of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw each 0.003~0.007 parts by volume of above-mentioned three kinds of solution, point sample is on same silica gel g thin-layer plate respectively, take volume ratio as 10~20: 2~8: cyclohexane-methylene chloride-ethyl acetate of 0.5~2 is developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launch, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the spot of the aobvious same color of test sample chromatogram;
B) the qualitative discriminating of cassia seed
Get described ten five tastes breast roc preparation 1~3 weight portions, porphyrize, add methyl alcohol 10~30 parts by volume, add hot reflux 20~45 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 10~30 parts by volume, ultrasonic processing 3~8 minutes, add again methenyl choloride 10~30 parts by volume, add hot reflux 20~45 minutes, cooling, in dislocation separating funnel, divide and get methenyl choloride layer, acid solution is extracted 1~3 time with methenyl choloride, each 5~15 parts by volume, merge methenyl choloride liquid, adding anhydrous sodium sulfate dewaters in right amount, filter, filtrate volatilizes, residue adds methyl alcohol 1~3 parts by volume to be made to dissolve, as the need testing solution of cassia seed, separately depend on pine torch control medicinal material 0.1~0.8g, be made in the same way of cassia seed control medicinal material solution, in prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution, according to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 0.005~0.02 parts by volume, control medicinal material solution 0.003~0.007 parts by volume and negative sample solution 0.005~0.02 parts by volume, point sample is on same silica gel g thin-layer plate respectively, with volume ratio 10~20: 2~8: 0.5~2, boiling point is that the upper strata liquid of 60 ℃~90 ℃ of sherwood oil-ethyl formate-formic acid is developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launch, take out, dry, put under 365nm ultraviolet lamp and inspect, in thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of the aobvious same color of test sample chromatogram,
C) the qualitative discriminating of Rhizoma Acori Calami
Get described ten five tastes breast roc preparation 1~3 weight portions, add methyl alcohol 10~30 parts by volume, ultrasonic 10~30 minutes, filter, filtrate is concentrated into approximately 1~3 parts by volume, as the need testing solution of Rhizoma Acori Calami; Separately get Rhizoma Acori Calami control medicinal material 0.1~0.8 weight portion, be made in the same way of Rhizoma Acori Calami control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 0.005~0.02 parts by volume, control medicinal material solution 0.003~0.007 parts by volume and negative sample solution 0.005~0.02 parts by volume, point sample is in same silica G F respectively 254on thin layer plate, take volume ratio as 5~15: 0.5~4, boiling point is that 60 ℃~90 ℃ petroleum ether-ethyl acetates are developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launches, and takes out, and dries, and puts under 254nm ultraviolet lamp and inspects; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the blackening point of the aobvious same color of test sample chromatogram;
D) Content of Aconitine inspection
Get described ten five tastes breast roc preparation 3~8 weight portions, porphyrize, adds ammonia solution 0.5~2 parts by volume, stirs evenly, place 1~3 hour, 10~20 parts by volume that add diethyl ether, jolting 0.5~2 hour, places 18~30 hours, filter, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 1~3 parts by volume to be made to dissolve, as the need testing solution of aconitine; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every parts by volume containing 0.0005~0.002 weight portion, as aconitine reference substance solution; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, draw need testing solution 0.005~0.03 parts by volume, aconitine reference substance solution 0.0015~0.015 parts by volume, point sample is on same silica gel g thin-layer plate respectively, take volume ratio as 2~8: 1~3: cyclohexane-ethyl acetate-diethylamine of 0.5~2 is developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launch, take out, dry, spray is with rare bismuth potassium iodide test solution; In thin layer test sample chromatogram, test sample chromatogram with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
More preferably, said method comprising the steps of:
I) the qualitative discriminating of radix jurineae
Get described ten five tastes breast roc preparation 2g, porphyrize, adds acetone 20ml, and ultrasonic processing 20 minutes filters, and filtrate concentrates about 2ml, as the need testing solution of radix jurineae; Separately get radix jurineae control medicinal material 0.5g, be made in the same way of radix jurineae control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 5 μ l of above-mentioned three kinds of solution, point sample is on same silica gel g thin-layer plate respectively, take volume ratio as the cyclohexane-methylene chloride-ethyl acetate of 15: 5: 1 is as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the spot of the aobvious same color of test sample chromatogram;
Ii) the qualitative discriminating of cassia seed
Get described ten five tastes breast roc preparation 2g, porphyrize, adds methyl alcohol 20ml, add hot reflux 30 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 20ml, ultrasonic processing 5 minutes, add again methenyl choloride 20ml, add hot reflux 30 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 2 times for acid solution, each 10ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, residue adds methyl alcohol 2ml to be made to dissolve, as the need testing solution of cassia seed; Separately depend on pine torch control medicinal material 0.5g, be made in the same way of cassia seed control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, point sample is on same silica gel g thin-layer plate respectively, with volume ratio 15: 5: 1, boiling point is that the upper strata liquid of 60 ℃~90 ℃ of sherwood oil-ethyl formate-formic acid is developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, put under 365nm ultraviolet lamp and inspect; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of the aobvious same color of test sample chromatogram;
Iii) the qualitative discriminating of Rhizoma Acori Calami
Get described ten five tastes breast roc preparation 2g, add methyl alcohol 20ml, ultrasonic 20 minutes, filter, filtrate is concentrated into about 2ml, as the need testing solution of Rhizoma Acori Calami; Separately get Rhizoma Acori Calami control medicinal material 0.5g, be made in the same way of Rhizoma Acori Calami control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5~10 μ l, control medicinal material solution 5 μ l and negative sample solution 5~10 μ l, point sample is in same silica G F respectively 254on thin layer plate, take volume ratio as 10: 2, boiling point is that 60 ℃~90 ℃ petroleum ether-ethyl acetates are developping agent, and thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, and dries, and puts under 254nm ultraviolet lamp and inspects; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the blackening point of the aobvious same color of test sample chromatogram;
Iv) Content of Aconitine inspection
Get described ten five tastes breast roc preparation 5g, porphyrize, adds ammonia solution 1ml, stirs evenly, place 2 hours, and the 15ml that adds diethyl ether, jolting 1 hour, places 24 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 2ml to be made to dissolve, as the need testing solution of aconitine; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 1mg, as aconitine reference substance solution; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, draw need testing solution 20 μ l, 10 μ l, aconitine reference substance solution 10 μ l, 5 μ l, 2.5 μ l, point sample is on same silica gel g thin-layer plate respectively, take volume ratio as the cyclohexane-ethyl acetate-diethylamine of 5: 2: 1 is as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, spray is with rare bismuth potassium iodide test solution; In thin-layer chromatography, test sample chromatogram with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
The formulation of above-mentioned ten five tastes breast roc preparations can be tablet, capsule, granule, pill or powder.Preparation method is: get described ten five tastes breast roc preparations, be ground into fine powder, sieve, mix, add suitable quantity of water pill, dry in the shade and get final product; Or get described ten five tastes breast roc preparations, and be ground into fine powder, sieve, mix, mix, by pharmacy conventional method, add conventional auxiliary material, make the oral formulations of accepting clinically.
The constituent that the present invention is directed to ten five tastes breast roc preparations, detects the existence of index composition radix jurineae, cassia seed, Rhizoma Acori Calami, and detects the content of the toxic component aconitine in preparation, to reach the object that the quality of preparation is controlled.Detection method of the present invention detects needs according to reality, and the testing conditions of existing detection method is screened, and has determined the preferably detection method of ten five tastes breast roc preparations, and that this detection method has is sensitive, favorable reproducibility and specificity strong feature.
Accompanying drawing explanation
Fig. 1 is radix jurineae thin-layer chromatography detection figure in ten five tastes breast roc preparations;
Wherein, from left to right sample order is: the need testing solution 3 of the need testing solution 1 of radix jurineae, the need testing solution 2 of radix jurineae, radix jurineae, the need testing solution 4 of radix jurineae, radix jurineae control medicinal material solution, not containing the negative sample solution of radix jurineae;
Wherein, developping agent is cyclohexane-methylene chloride-ethyl acetate (15: 5: 1), and developer is 5% vanillic aldehyde sulfuric acid.
Fig. 2 is cassia seed thin-layer chromatography detection figure in ten five tastes breast roc preparations;
Wherein, from left to right sample order is: the need testing solution 3 of the need testing solution 1 of cassia seed, the need testing solution 2 of cassia seed, cassia seed, the need testing solution 4 of cassia seed, cassia seed control medicinal material solution, cassia seed control medicinal material solution, not containing the negative sample solution of cassia seed;
Wherein, developping agent is the upper strata liquid of sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (15: 5: 1), under ultraviolet lamp (365nm), inspects.
Fig. 3 is Rhizoma Acori Calami thin-layer chromatography detection figure in ten five tastes breast roc preparations;
Wherein from left to right sample order is: the need testing solution 3 of the need testing solution 1 of Rhizoma Acori Calami, the need testing solution 2 of Rhizoma Acori Calami, Rhizoma Acori Calami, the need testing solution 4 of Rhizoma Acori Calami, Rhizoma Acori Calami control medicinal material solution, Rhizoma Acori Calami control medicinal material solution, not containing the negative controls of Rhizoma Acori Calami;
Wherein, developping agent is sherwood oil (60 ℃~90 ℃)-ethyl acetate (10: 2), under ultraviolet lamp (254nm), inspects.
Fig. 4 is ten five tastes breast roc preparation mesaconitine content detection figure;
Wherein from left to right sample order is: (point sample amount 10 μ l) for the need testing solution 1 that Content of Aconitine detects, (point sample amount 10 μ l) for the need testing solution 2 that Content of Aconitine detects, (point sample amount 10 μ l) for the need testing solution 3 that Content of Aconitine detects, (point sample amount 5 μ l) for aconitine reference substance solution 1, (point sample amount 10 μ l) for aconitine reference substance solution 2, (point sample amount 20 μ l) for the need testing solution 4 that Content of Aconitine detects, (point sample amount 20 μ l) for the need testing solution 5 that Content of Aconitine detects, (point sample amount 20 μ l) for the need testing solution 6 that Content of Aconitine detects, (point sample amount 2.5 μ l) for aconitine reference substance solution, (point sample amount 2.5 μ l) for aconitine reference substance solution,
Wherein, developping agent is cyclohexane-ethyl acetate-diethylamine (5: 2: 1), and developer is rare bismuth iodide test solution; Under daylight, inspect.
Embodiment
The following preparation for each composition detection all referred to as " test sample ", is interpreted as the test sample that it refers to require according to each detection method preparation under each detection method, for example, at the test sample described in radix jurineae method, be " test sample of radix jurineae ".
The preparation of [embodiment 1] ten five tastes breast roc preparations
Frankincense 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled to cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g, slagging-off is tamed and dociled outside cream, Moschus or muscone, all the other are ground into fine powder, sieve, add Moschus or muscone's fine powder, mix, with slag, tame and docile cream and add suitable quantity of water pill, dry in the shade and get final product.Or above ten five tastes, except Moschus or muscone, all the other are ground into fine powder, sieve, add Moschus or muscone's fine powder, mix, by pharmacy conventional method, add conventional auxiliary material, make the oral formulations of accepting clinically: granule, pill, capsule, tablet or powder.
Usage and consumption: a day dose is 1.2-2.4g crude drug amount, 2 times on the one.
The screening experiment of the thin-layer chromatography condition of radix jurineae in [embodiment 2] ten five tastes breast roc preparations
(1) instrument
Mortar, electronic scales, tool plug conical flask, transfer pipet, ultrasound wave extraction apparatus, funnel, filter paper, evaporating dish, sample applicator, silica G plate, chromatography cylinder, spray bottle, hair dryer.
(2) control medicinal material
Radix jurineae control medicinal material (lot number: 1091-200001), purchased from Nat'l Pharmaceutical & Biological Products Control Institute.
(3) reagent
Ether, cyclohexane, acetone, sherwood oil (60 ℃~90 ℃), ethyl formate, formic acid, ethyl acetate, methylene chloride, 5% vanillic aldehyde sulfuric acid.
(4) method of inspection:
Extract the selection of solvent: adopt respectively ether and acetone for extracting solvent;
The selection of extracting method: adopt respectively ultrasonic processing and add hot reflux;
The selection of developping agent: respectively take cyclohexane-acetone (10: 3), sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (15: 5: 0.5), sherwood oil (60 ℃~90 ℃)-ethyl acetate (9: 1), cyclohexane-methylene chloride-ethyl acetate (15: 5: 1) as developping agent.
(5) select respectively above different solvents, extracting method and developping agent to test, result is as follows
Figure BDA0000121301120000081
Repetition test in the above conditions, finally determines preferred detection method, specific as follows:
Get described ten five tastes breast roc preparation 2g, porphyrize, adds acetone 20ml, and ultrasonic processing 20 minutes filters, and filtrate concentrates about 2ml, as need testing solution; Separately get radix jurineae control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 5 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take volume ratio as the cyclohexane-methylene chloride-ethyl acetate of 15: 5: 1 is as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the spot of aobvious same color, as shown in Figure 1.The method operates through many people test of many times, favorable reproducibility, and specificity is strong, can be used as the detection method of radix jurineae in ten five tastes breast roc preparations.
The screening experiment of the thin-layer chromatography condition of cassia seed in [embodiment 3] ten five tastes breast roc preparations
(1) instrument
Mortar, electronic scales, tool plug conical flask, transfer pipet, ultrasound wave extraction apparatus, funnel, filter paper, evaporating dish, sample applicator, silica G plate, chromatography cylinder, spray bottle, hair dryer.
(2) control medicinal material
Cassia seed control medicinal material (lot number: 1211011-200403), purchased from Nat'l Pharmaceutical & Biological Products Control Institute.
(3) reagent
Methyl alcohol, 95% ethanol, 2.5mol/L sulfuric acid solution, methenyl choloride, anhydrous sodium sulfate, sherwood oil (60 ℃~90 ℃), ethyl formate, formic acid.
(4) method of inspection:
Extract the selection of solvent: adopt respectively methyl alcohol and 95% ethanol for extracting solvent;
The selection of extracting method: adopt respectively dipping, add hot reflux, ultrasonic extraction;
The selection of developping agent: respectively take the upper strata liquid of sherwood oil (30~60 ℃)-acetone (2: 1), sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (15: 5: 1) as developping agent.
(5) select respectively above different solvents, extracting method and developping agent to test, result is as follows:
Figure BDA0000121301120000091
Repetition test in the above conditions, has finally determined cassia seed preferred detection method, specific as follows:
Get described ten five tastes breast roc preparation 2g, porphyrize, adds methyl alcohol 20ml, adds hot reflux 30 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 20ml, ultrasonic processing 5 minutes, add again methenyl choloride 20ml, add hot reflux 30 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 2 times for acid solution, each 10ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, and residue adds methyl alcohol 2ml to be made to dissolve, as need testing solution; Separately depend on pine torch control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, put respectively on same silica gel g thin-layer plate, with volume ratio 15: 5: 1, boiling point is that the upper strata liquid of 60 ℃~90 ℃ of sherwood oil-ethyl formate-formic acid is developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, put under 365nm ultraviolet lamp and inspect; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of aobvious same color.As shown in Figure 2.The method operates through many people test of many times, favorable reproducibility, and specificity is strong, can be used as the detection method of cassia seed in ten five tastes breast roc preparations.
The screening experiment of the thin-layer chromatography condition of Rhizoma Acori Calami in [embodiment 4] ten five tastes breast roc preparations
(1) instrument
Mortar, electronic scales, tool plug conical flask, transfer pipet, ultrasound wave extraction apparatus, funnel, filter paper, evaporating dish, sample applicator, silica G and GF254 thin layer plate, chromatography cylinder, spray bottle, hair dryer.
(2) control medicinal material
Rhizoma Acori Calami control medicinal material (lot number: 121084-200502), purchased from Nat'l Pharmaceutical & Biological Products Control Institute.
(3) reagent
Methyl alcohol, ether, sherwood oil (60 ℃~90 ℃), ethyl acetate, normal hexane, formic acid.
(4) method of inspection:
Extract the selection of solvent: adopt respectively methyl alcohol and ether for extracting solvent;
The selection of thin layer plate: adopt respectively silica gel g thin-layer plate and silica GF254 thin layer plate;
The selection of developping agent: respectively take the upper strata liquid of sherwood oil (30~60 ℃)-ethyl acetate (10: 2), normal hexane-ethyl acetate-formic acid (9: 1: 1) as developping agent.
(5) select respectively above different solvents, thin layer plate and developping agent to test, result is as follows:
Figure BDA0000121301120000101
Figure BDA0000121301120000111
Repetition test in the above conditions, has finally determined the preferred detection method of Rhizoma Acori Calami, specific as follows:
Get described ten five tastes breast roc preparation 2g, porphyrize, adds methyl alcohol 20ml, and ultrasonic 20 minutes, filter, filtrate is concentrated into about 2ml, as need testing solution; Separately get Rhizoma Acori Calami control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5~10 μ l, control medicinal material solution 5 μ l and negative sample solution 5~10 μ l, put respectively in same silica G F 254on thin layer plate, take volume ratio as 10: 2, boiling point is that 60 ℃~90 ℃ petroleum ether-ethyl acetates are developping agent, and thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, and dries, and puts under 254nm ultraviolet lamp and inspects; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the blackening point of aobvious same color.As shown in Figure 3.The method operates through many people test of many times, favorable reproducibility, and specificity is strong, can be used as the detection method of Rhizoma Acori Calami in ten five tastes breast roc preparations.
The screening experiment of the thin-layer chromatography condition of [embodiment 5] ten five tastes breast roc preparation mesaconitine content
(1) instrument
Mortar, electronic scales, tool plug conical flask, transfer pipet, ultrasound wave extraction apparatus, funnel, filter paper, evaporating dish, sample applicator, silica gel g thin-layer plate, chromatography cylinder, spray bottle, hair dryer.
(2) reference substance
Aconitine reference substance (lot number: 320756035164), purchased from Nat'l Pharmaceutical & Biological Products Control Institute.
(3) reagent
Ammonia solution, ether, absolute ethyl alcohol, cyclohexane, benzene, ethyl acetate, diethylamine, methylene chloride, acetone, methyl alcohol, rare bismuth potassium iodide, improvement bismuth potassium iodide test solution.
(4) extracting method
The selection of developping agent: respectively take benzene-ethyl acetate-ethylenediamine (14: 4: 1), cyclohexane-ethyl acetate-ethylenediamine (14: 4: 1), cyclohexane-ethyl acetate-diethylamine (5: 2: 1), methylene chloride-acetone-methyl alcohol (6: 1: 1) as developping agent;
The selection of developer: respectively take rare bismuth potassium iodide test solution and improvement bismuth potassium iodide test solution as colour developing.
(5) select respectively above different developping agents and developer to test, result is as follows:
Figure BDA0000121301120000112
Figure BDA0000121301120000121
Repetition test in the above conditions, finally determined the preferred detection method of Content of Aconitine:
Get described ten five tastes breast roc preparation 5g, porphyrize, adds ammonia solution 1ml, stirs evenly, place 2 hours, and the 15ml that adds diethyl ether, jolting 1 hour, places 24 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 2ml to be made to dissolve, as need testing solution; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 1mg, product solution in contrast; According to thin-layered chromatography test described in 2010 editions one appendix VI B of < < Chinese Pharmacopoeia > >, accurate need testing solution 20 μ l, the 10 μ l of drawing, aconitine reference substance solution 10 μ l, 5 μ l, 2.5 μ l, put respectively on same silica gel g thin-layer plate, take cyclohexane-ethyl acetate-diethylamine (5: 2: 1) as developping agent, launch, take out, dry, spray is with rare bismuth potassium iodide test solution; In test sample chromatogram, with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot, as shown in Figure 4.The method operates through many people test of many times, favorable reproducibility, and specificity is strong, can be used as the detection method of ten five tastes breast roc preparation mesaconitine.
[test example 1]: the detection of ten five tastes breast roc balls
Shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g;
Above ten five tastes, slagging-off is tamed and dociled outside cream, Moschus or muscone, and all the other are ground into fine powder, sieve, and add Moschus or muscone's fine powder, mix, and tame and docile cream add suitable quantity of water pill with slag, dry in the shade and get final product.
A. the thin layer of radix jurineae is differentiated
Get described ten five tastes breast roc ball 2g, porphyrize, adds acetone 20ml, and ultrasonic processing 20 minutes filters, and filtrate concentrates about 2ml, as need testing solution; Separately get radix jurineae control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 5 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take volume ratio as the cyclohexane-methylene chloride-ethyl acetate of 15: 5: 1 is as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the spot of aobvious same color.
B. the thin layer of cassia seed is differentiated
Get described ten five tastes breast roc ball 2g, porphyrize, adds methyl alcohol 20ml, adds hot reflux 30 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 20ml, ultrasonic processing 5 minutes, add again methenyl choloride 20ml, add hot reflux 30 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 2 times for acid solution, each 10ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, and residue adds methyl alcohol 2ml to be made to dissolve, as need testing solution; Separately depend on pine torch control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, put respectively on same silica gel g thin-layer plate, with volume ratio 15: 5: 1, boiling point is that the upper strata liquid of 60 ℃~90 ℃ of sherwood oil-ethyl formate-formic acid is developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, put under 365nm ultraviolet lamp and inspect; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of aobvious same color.
C. the thin layer of Rhizoma Acori Calami is differentiated
Get described ten five tastes breast roc ball 2g, add methyl alcohol 20ml, ultrasonic 20 minutes, filter, filtrate is concentrated into about 2ml, as need testing solution; Separately get Rhizoma Acori Calami control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5~10 μ l, control medicinal material solution 5 μ l and negative sample solution 5~10 μ l, put respectively in same silica G F 254on thin layer plate, take volume ratio as 10: 2, boiling point is that 60 ℃~90 ℃ petroleum ether-ethyl acetates are developping agent, and thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, and dries, and puts under 254nm ultraviolet lamp and inspects; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the blackening point of aobvious same color.
D. the content inspection of aconitine
Get described ten five tastes breast roc ball 5g, porphyrize, adds ammonia solution 1ml, stirs evenly, place 2 hours, and the 15ml that adds diethyl ether, jolting 1 hour, places 24 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 2ml to be made to dissolve, as need testing solution; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 1mg, product solution in contrast; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, draw need testing solution 10 μ l and aconitine reference substance solution 2.5 μ l, negative sample solution 10 μ l, put respectively on same silica gel g thin-layer plate, take volume ratio as the cyclohexane-ethyl acetate-diethylamine of 5: 2: 1 is as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, spray is with rare bismuth potassium iodide test solution; In test sample chromatogram, with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
[test example 2]: the detection of ten five tastes breast roc sheets
Shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g;
Above ten five tastes, except Moschus or muscone, all the other are ground into fine powder, sieve, and add Moschus or muscone's fine powder, mix, and by pharmacy conventional method, add conventional auxiliary material, make acceptable ten five tastes breast roc sheets clinically.
A. the thin layer of radix jurineae is differentiated
Get above-mentioned ten five tastes breast roc sheet 1g, porphyrize, adds acetone 10ml, and ultrasonic processing 10 minutes filters, and filtrate is waved to about 1ml, as need testing solution; Separately get radix jurineae control medicinal material 0.3g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 3 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take cyclohexane-methylene chloride-ethyl acetate (12: 3: 0.8) as developping agent, thin layer plate is put saturated 10min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the spot of aobvious same color.
B. the thin layer of cassia seed is differentiated
Get above-mentioned ten five tastes breast roc sheet 3g, porphyrize, adds methyl alcohol 30ml, adds hot reflux 45 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 30ml, ultrasonic processing 8 minutes, add again methenyl choloride 30ml, add hot reflux 45 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 3 times for acid solution, each 5ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, and residue adds methyl alcohol 3ml to be made to dissolve, as need testing solution; Separately depend on pine torch control medicinal material 0.8g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 15 μ l, control medicinal material solution 7 μ l and negative sample solution 15 μ l, put respectively on same silica gel g thin-layer plate, take the upper strata liquid of sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (17: 6: 1.5) as developping agent, thin layer plate is put saturated 30min in expansion cylinder, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of aobvious same color, and spot separates better, without hangover, negative without obviously disturbing.C. the limit examine of aconitine
C. the content inspection of aconitine
Get above-mentioned ten five tastes breast roc sheet 8g, porphyrize, adds ammonia solution 2ml, stirs evenly, place 3 hours, and the 20ml that adds diethyl ether, jolting 2 hours, places 30 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 3ml to be made to dissolve, as need testing solution; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 1.5mg, product solution in contrast; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, accurate need testing solution 15 μ l and the aconitine reference substance solution 5 μ l of drawing, put respectively on same silica gel g thin-layer plate, take cyclohexane-ethyl acetate-diethylamine (7: 2.4: 1.3) as developping agent, thin layer plate is put saturated 30min in expansion cylinder, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In test sample chromatogram, with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
[test example 3]: the detection of ten five tastes breast roc hard shell capsules
Shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g;
Above ten five tastes, except Moschus or muscone, all the other are ground into fine powder, sieve, and add Moschus or enter muscone's fine powder, mix, and by pharmacy conventional method, add conventional auxiliary material, make acceptable ten five tastes breast roc hard shell capsules clinically.
A. the thin layer of radix jurineae is differentiated
Get above-mentioned ten five tastes breast roc hard shell capsules content 2g, porphyrize, adds acetone 20ml, and ultrasonic processing 20 minutes filters, and filtrate is waved to about 2ml, as need testing solution; Separately get radix jurineae control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 5 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take cyclohexane-methylene chloride-ethyl acetate (15: 5: 1) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the spot of aobvious same color.
B. the thin layer of Rhizoma Acori Calami is differentiated
Get above-mentioned ten five tastes breast roc hard shell capsules content 1g, add methyl alcohol 120ml, ultrasonic 10 minutes, filter, filtrate is concentrated into about 1ml, as need testing solution; Separately get Rhizoma Acori Calami control medicinal material 0.3g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5 μ l, control medicinal material solution 3 μ l and negative sample solution 5 μ l, put respectively in same silica G F 254on thin layer plate, take sherwood oil (60 ℃~90 ℃)-ethyl acetate (7: 0.8) as developping agent, thin layer plate is put saturated 10min in expansion cylinder, launches, and takes out, and dries, and puts under ultraviolet lamp (254nm) and inspects; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the blackening point of aobvious same color.
C. the limit examine of aconitine
Get above-mentioned ten five tastes breast roc hard shell capsules 3g, porphyrize, adds ammonia solution 0.5ml, stirs evenly, place 1 hour, and the 10ml that adds diethyl ether, jolting 0.5 hour, places 18 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 1ml to be made to dissolve, as need testing solution; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 0.5mg, product solution in contrast; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, accurate need testing solution 5 μ l and the aconitine reference substance solution 1.5 μ l of drawing, put respectively on same silica gel g thin-layer plate, take cyclohexane-ethyl acetate-diethylamine (3: 1.2: 0.7) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In test sample chromatogram, with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
[test example 4]: the detection of ten five tastes breast roc particles
Shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g;
Above ten five tastes, except Moschus or muscone, all the other are ground into fine powder, sieve, and add Moschus or muscone's fine powder, mix, and by pharmacy conventional method, add conventional auxiliary material, make acceptable ten five tastes breast roc particles clinically.
A. the thin layer of radix jurineae is differentiated
Get above-mentioned ten five tastes breast roc particle 3g, porphyrize, adds acetone 30ml, and ultrasonic processing 30 minutes filters, and filtrate is waved to about 3ml, as need testing solution; Separately get radix jurineae control medicinal material 0.8g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 7 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take cyclohexane-methylene chloride-ethyl acetate (18: 7: 1.5) as developping agent, thin layer plate is put saturated 30min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the spot of aobvious same color.
B. the thin layer of cassia seed is differentiated
Get above-mentioned ten five tastes breast roc particle 1g, porphyrize, adds methyl alcohol 10ml, adds hot reflux 20 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 10ml, ultrasonic processing 3 minutes, add again methenyl choloride 10ml, add hot reflux 20 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 1 time for acid solution, each 15ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, and residue adds methyl alcohol 1ml to be made to dissolve, as need testing solution; Separately depend on pine torch control medicinal material 0.3g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5 μ l, control medicinal material solution 3 μ l and negative sample solution 5 μ l, put respectively on same silica gel g thin-layer plate, take the upper strata liquid of sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (12: 2: 0.8) as developping agent, thin layer plate is put saturated 10min in expansion cylinder, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of aobvious same color, and spot separates better, without hangover, negative without obviously disturbing.
C. the thin layer of Rhizoma Acori Calami is differentiated
Get above-mentioned ten five tastes breast roc particle 2g, add methyl alcohol 20ml, ultrasonic 20 minutes, filter, filtrate is concentrated into about 2ml, as need testing solution; Separately get Rhizoma Acori Calami control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, put respectively in same silica G F 254on thin layer plate, take sherwood oil (60 ℃~90 ℃)-ethyl acetate (10: 2) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, and dries, and puts under ultraviolet lamp (254nm) and inspects; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the blackening point of aobvious same color.
[test example 5]: the loose detection of ten five tastes breast rocs
Shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, the banksia rose/radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g;
Above ten five tastes, except Moschus or muscone, all the other are ground into fine powder, sieve, and add Moschus or muscone's fine powder, mix, and by pharmacy conventional method, add conventional auxiliary material, make acceptable ten five tastes breast rocs clinically and fall apart.
A. the thin layer of cassia seed is differentiated
Get the loose 2g of above-mentioned ten five tastes breast roc, porphyrize, adds methyl alcohol 20ml, adds hot reflux 30 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 20ml, ultrasonic processing 5 minutes, add again methenyl choloride 20ml, add hot reflux 30 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 2 times for acid solution, each 10ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, and residue adds methyl alcohol 2ml to be made to dissolve, as need testing solution; Separately depend on pine torch control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes not containing cassia seed negative sample solution by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, put respectively on same silica gel g thin-layer plate, take the upper strata liquid of sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (15: 5: 1) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of aobvious same color, and spot separates better, without hangover, negative without obviously disturbing.
B. the thin layer of Rhizoma Acori Calami is differentiated
Get the loose 1g of above-mentioned ten five tastes breast roc, add methyl alcohol 120ml, ultrasonic 10 minutes, filter, filtrate is concentrated into about 1ml, as need testing solution; Separately get Rhizoma Acori Calami control medicinal material 0.3g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5 μ l, control medicinal material solution 3 μ l and negative sample solution 5 μ l, put respectively in same silica G F 254on thin layer plate, take sherwood oil (60 ℃~90 ℃)-ethyl acetate (7: 0.8) as developping agent, thin layer plate is put saturated 10min in expansion cylinder, launches, and takes out, and dries, and puts under ultraviolet lamp (254nm) and inspects; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the blackening point of aobvious same color.
C. the limit examine of aconitine
Get the loose 3g of above-mentioned ten five tastes breast roc, porphyrize, adds ammonia solution 0.5ml, stirs evenly, place 1 hour, and the 10ml that adds diethyl ether, jolting 0.5 hour, places 18 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol lml to be made to dissolve, as need testing solution; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 0.5mg, product solution in contrast; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, accurate need testing solution 20 μ l and the aconitine reference substance solution 10 μ l of drawing, put respectively on same silica gel g thin-layer plate, take cyclohexane-ethyl acetate-diethylamine (3: 1.2: 0.7) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In test sample chromatogram, with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
[test example 6]: the detection of ten five tastes breast roc soft capsules
Shellfish main officer of Tibet 150g, wide muscle rattan 150g, cassia seed 120g, slag are tamed and dociled cream 75g, Semen seu folium abelmoschi moschati 120g, Rhizoma Acori Calami 120g, BAXIAGA 110g, catechu 75g, myrobalan 150g, styrax/bitter Kui Nabu 60g, the terminaliae billericae,fructus 150g of stoning, Aconitum Szechenyianum Gay (system) 75g, banksia rose radix jurineae 150g, Moschus/muscone 1.5g, emblic 150g;
Above ten five tastes, except Moschus or muscone, all the other are ground into fine powder, sieve, and add Moschus or muscone's fine powder, mix, and by pharmacy conventional method, add conventional auxiliary material, make acceptable ten five tastes breast roc soft capsules clinically.
A. the thin layer of radix jurineae is differentiated
Get above-mentioned ten five tastes breast roc soft capsule 3g, porphyrize, adds acetone 30ml, and ultrasonic processing 30 minutes filters, and filtrate is waved to about 3ml, as need testing solution; Separately get radix jurineae control medicinal material 0.8g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 7 μ l of above-mentioned three kinds of solution, put respectively on same silica gel g thin-layer plate, take cyclohexane-methylene chloride-ethyl acetate (18: 7: 1.5) as developping agent, thin layer plate is put saturated 30min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the spot of aobvious same color.
B. the thin layer of cassia seed is differentiated
Get above-mentioned ten five tastes breast roc soft capsule 1g, porphyrize, adds methyl alcohol 10ml, adds hot reflux 20 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 10ml, ultrasonic processing 3 minutes, add again methenyl choloride 10ml, add hot reflux 20 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 1 time for acid solution, each 15ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, and residue adds methyl alcohol 1ml to be made to dissolve, as need testing solution; Separately depend on pine torch control medicinal material 0.3g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5 μ l, control medicinal material solution 3 μ l and negative sample solution 5 μ l, put respectively on same silica gel g thin-layer plate, take the upper strata liquid of sherwood oil (60 ℃~90 ℃)-ethyl formate-formic acid (12: 2: 0.8) as developping agent, thin layer plate is put saturated 10min in expansion cylinder, launch, take out, dry, put under ultraviolet lamp (365nm) and inspect; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of aobvious same color, and spot separates better, without hangover, negative without obviously disturbing.
C. the thin layer of Rhizoma Acori Calami is differentiated
Get above-mentioned ten five tastes breast roc soft capsule 2g, add methyl alcohol 20ml, ultrasonic 20 minutes, filter, filtrate is concentrated into about 2ml, as need testing solution; Separately get Rhizoma Acori Calami control medicinal material 0.5g, be made in the same way of control medicinal material solution; In prescription ratio and preparation technology, configuration does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution.According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, put respectively in same silica G F 254on thin layer plate, take sherwood oil (60 ℃~90 ℃)-ethyl acetate (10: 2) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, and dries, and puts under ultraviolet lamp (254nm) and inspects; In test sample chromatogram, with the corresponding position of control medicinal material chromatogram on, the blackening point of aobvious same color.
D. the limit examine of aconitine
Get above-mentioned ten five tastes breast roc soft capsule 5g, porphyrize, adds ammonia solution 1ml, stirs evenly, place 2 hours, and the 15ml that adds diethyl ether, jolting 1 hour, places 24 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 2ml to be made to dissolve, as need testing solution; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 1mg, product solution in contrast; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, accurate need testing solution 10 μ l and the aconitine reference substance solution 2.5 μ l of drawing, put respectively on same silica gel g thin-layer plate, take cyclohexane-ethyl acetate-diethylamine (5: 2: 1) as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, dry, spray is with rare bismuth potassium iodide test solution; In test sample chromatogram, with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.

Claims (4)

1. a detection method for ten five tastes breast roc preparations, said preparation bulk drug consists of: frankincense 150 weight portions, wide muscle rattan 150 weight portions, cassia seed 120 weight portions, slag are tamed and dociled cream 75 weight portions, Semen seu folium abelmoschi moschati 120 weight portions, Rhizoma Acori Calami 120 weight portions, BAXIAGA 110 weight portions, catechu 75 weight portions, myrobalan's 150 weight portions of stoning, styrax/bitter Kui Nabu 60 weight portions, terminaliae billericae,fructus 150 weight portions, Aconitum Szechenyianum Gay processed 75 weight portions, the banksia rose/radix jurineae 150 weight portions, Moschus/muscone's 1.5 weight portions, emblic 150 weight portions;
The method comprises following discriminating and/or inspection method, comprises the following steps:
A) the qualitative discriminating of radix jurineae
Get described ten five tastes breast roc preparation 1~3 weight portions, porphyrize, adds acetone 10~30 parts by volume, and ultrasonic processing 10~30 minutes filters, and filtrate concentrates approximately 1~3 parts by volume, as the need testing solution of radix jurineae; Separately get radix jurineae control medicinal material 0.1~0.8 weight portion, be made in the same way of radix jurineae control medicinal material solution; In prescription ratio and preparation technology, preparation does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution; According to 2010 editions appendix VIB tests of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw each 0.003~0.007 parts by volume of above-mentioned three kinds of solution, point sample is on same silica gel g thin-layer plate respectively, cyclohexane-methylene chloride-ethyl acetate take volume ratio as 10~20:2~8:0.5~2 is developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launch, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the spot of the aobvious same color of test sample chromatogram;
B) the qualitative discriminating of cassia seed
Get described ten five tastes breast roc preparation 1~3 weight portions, porphyrize, add methyl alcohol 10~30 parts by volume, add hot reflux 20~45 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 10~30 parts by volume, ultrasonic processing 3~8 minutes, add again methenyl choloride 10~30 parts by volume, add hot reflux 20~45 minutes, cooling, in dislocation separating funnel, divide and get methenyl choloride layer, acid solution is extracted 1~3 time with methenyl choloride, each 5~15 parts by volume, merge methenyl choloride liquid, adding anhydrous sodium sulfate dewaters in right amount, filter, filtrate volatilizes, residue adds methyl alcohol 1~3 parts by volume to be made to dissolve, as the need testing solution of cassia seed, separately depend on pine torch control medicinal material 0.1~0.8g, be made in the same way of cassia seed control medicinal material solution, in prescription ratio and preparation technology, preparation does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution, according to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 0.005~0.02 parts by volume, control medicinal material solution 0.003~0.007 parts by volume and negative sample solution 0.005~0.02 parts by volume, point sample is on same silica gel g thin-layer plate respectively, with volume ratio 10~20: 2~8: 0.5~2, boiling point is that the upper strata liquid of 60 ℃~90 ℃ of sherwood oil-ethyl formate-formic acid is developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launch, take out, dry, put under 365nm ultraviolet lamp and inspect, in thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of the aobvious same color of test sample chromatogram,
C) the qualitative discriminating of Rhizoma Acori Calami
Get described ten five tastes breast roc preparation 1~3 weight portions, add methyl alcohol 10~30 parts by volume, ultrasonic 10~30 minutes, filter, filtrate is concentrated into approximately 1~3 parts by volume, as the need testing solution of Rhizoma Acori Calami; Separately get Rhizoma Acori Calami control medicinal material 0.1~0.8 weight portion, be made in the same way of Rhizoma Acori Calami control medicinal material solution; In prescription ratio and preparation technology, preparation does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 0.005~0.02 parts by volume, control medicinal material solution 0.003~0.007 parts by volume and negative sample solution 0.005~0.02 parts by volume, point sample is in same silica G F respectively 254on thin layer plate, take volume ratio as 5~15:0.5~4, boiling point is that 60 ℃~90 ℃ petroleum ether-ethyl acetates are developping agent, and thin layer plate is put saturated 0~40min in expansion cylinder, launches, and takes out, and dries, and puts under 254nm ultraviolet lamp and inspects; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the blackening point of the aobvious same color of test sample chromatogram;
D) Content of Aconitine inspection
Get described ten five tastes breast roc preparation 3~8 weight portions, porphyrize, adds ammonia solution 0.5~2 parts by volume, stirs evenly, place 1~3 hour, 10~20 parts by volume that add diethyl ether, jolting 0.5~2 hour, places 18~30 hours, filter, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 1~3 parts by volume to be made to dissolve, as the need testing solution of aconitine; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every parts by volume containing 0.0005~0.002 weight portion, as aconitine reference substance solution; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, draw need testing solution 0.005~0.03 parts by volume, aconitine reference substance solution 0.0015~0.015 parts by volume, point sample is on same silica gel g thin-layer plate respectively, take volume ratio as 2~8: 1~3: cyclohexane-ethyl acetate-diethylamine of 0.5~2 is developping agent, thin layer plate is put saturated 0~40min in expansion cylinder, launch, take out, dry, spray is with rare bismuth potassium iodide test solution; In thin layer test sample chromatogram, test sample chromatogram with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
2. detection method as claimed in claim 1, comprises the following steps:
I) the qualitative discriminating of radix jurineae
Get described ten five tastes breast roc preparation 2g, porphyrize, adds acetone 20ml, and ultrasonic processing 20 minutes filters, and filtrate concentrates about 2ml, as the need testing solution of radix jurineae; Separately get radix jurineae control medicinal material 0.5g, be made in the same way of radix jurineae control medicinal material solution; In prescription ratio and preparation technology, preparation does not contain the negative sample of radix jurineae, and makes the not negative sample solution containing radix jurineae by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw the each 5 μ l of above-mentioned three kinds of solution, point sample is on same silica gel g thin-layer plate respectively, cyclohexane-methylene chloride-ethyl acetate take volume ratio as 15:5:1 is developping agent, and thin layer plate is put saturated 20min in expansion cylinder, launches, take out, dry, spray is with 5% vanillic aldehyde sulfuric acid solution, and it is clear that hot blast blows to spot colour developing; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the spot of the aobvious same color of test sample chromatogram;
Ii) the qualitative discriminating of cassia seed
Get described ten five tastes breast roc preparation 2g, porphyrize, adds methyl alcohol 20ml, add hot reflux 30 minutes, filter, filtrate evaporate to dryness, residue adds 2.5mol/L sulfuric acid solution 20ml, ultrasonic processing 5 minutes, add again methenyl choloride 20ml, add hot reflux 30 minutes, cooling, in dislocation separating funnel, point get methenyl choloride layer, methenyl choloride extracts 2 times for acid solution, each 10ml, merge methenyl choloride liquid, add anhydrous sodium sulfate and dewater in right amount, filter, filtrate volatilizes, residue adds methyl alcohol 2ml to be made to dissolve, as the need testing solution of cassia seed; Separately depend on pine torch control medicinal material 0.5g, be made in the same way of cassia seed control medicinal material solution; In prescription ratio and preparation technology, preparation does not contain the negative sample of cassia seed, and makes the not negative sample solution containing cassia seed by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 10 μ l, control medicinal material solution 5 μ l and negative sample solution 10 μ l, point sample is on same silica gel g thin-layer plate respectively, with volume ratio 15: 5: 1, boiling point is that the upper strata liquid of 60 ℃~90 ℃ of sherwood oil-ethyl formate-formic acid is developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, put under 365nm ultraviolet lamp and inspect; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the fluorescence spot of the aobvious same color of test sample chromatogram;
Iii) the qualitative discriminating of Rhizoma Acori Calami
Get described ten five tastes breast roc preparation 2g, add methyl alcohol 20ml, ultrasonic 20 minutes, filter, filtrate is concentrated into about 2ml, as the need testing solution of Rhizoma Acori Calami; Separately get Rhizoma Acori Calami control medicinal material 0.5g, be made in the same way of Rhizoma Acori Calami control medicinal material solution; In prescription ratio and preparation technology, preparation does not contain the negative sample of Rhizoma Acori Calami, and makes the not negative sample solution containing Rhizoma Acori Calami by the preparation method of described need testing solution; According to 2010 editions one appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > >, draw need testing solution 5~10 μ l, control medicinal material solution 5 μ l and negative sample solution 5~10 μ l, point sample is in same silica G F respectively 254on thin layer plate, take volume ratio as 10:2, boiling point is that 60 ℃~90 ℃ petroleum ether-ethyl acetates are developping agent, and thin layer plate is put saturated 20min in expansion cylinder, launches, and takes out, and dries, and puts under 254nm ultraviolet lamp and inspects; In thin-layer chromatography, with the corresponding position of control medicinal material chromatogram on, the blackening point of the aobvious same color of test sample chromatogram;
Iv) Content of Aconitine inspection
Get described ten five tastes breast roc preparation 5g, porphyrize, adds ammonia solution 1ml, stirs evenly, place 2 hours, and the 15ml that adds diethyl ether, jolting 1 hour, places 24 hours, filters, filtrate evaporate to dryness, residue adds absolute ethyl alcohol 2ml to be made to dissolve, as the need testing solution of aconitine; Separately get aconitine reference substance appropriate, add absolute ethyl alcohol and make the solution of every 1ml containing 1mg, as aconitine reference substance solution; According to appendix VI B test of thin-layered chromatography < < Chinese Pharmacopoeia > > version in 2010, draw need testing solution 20 μ l, 10 μ l, aconitine reference substance solution 10 μ l, 5 μ l, 2.5 μ l, point sample is on same silica gel g thin-layer plate respectively, take volume ratio as the cyclohexane-ethyl acetate-diethylamine of 5: 2: 1 is as developping agent, thin layer plate is put saturated 20min in expansion cylinder, launch, take out, dry, spray is with rare bismuth potassium iodide test solution; In thin-layer chromatography, test sample chromatogram with the corresponding position of reference substance chromatogram on the spot that occurs should be less than the spot of reference substance or not occur spot.
3. the detection method as described in any one in claim 1 to 2, is characterized in that, the formulation of described ten five tastes breast roc preparations is tablet, capsule, granule, pill or powder.
4. the detection method as described in claim 1 to 2 any one, is characterized in that, gets the bulk drug of described weight portion, is ground into fine powder, sieves, and mixes, and adds suitable quantity of water pill, dries in the shade and get final product; Or get the bulk drug of described weight portion, and be ground into fine powder, sieve, mix, by pharmacy conventional method, add conventional auxiliary material, make the oral formulations of accepting clinically.
CN201110427293.8A 2011-12-16 2011-12-16 Detection method for fifteen Rupeng preparation Active CN102520113B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110427293.8A CN102520113B (en) 2011-12-16 2011-12-16 Detection method for fifteen Rupeng preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110427293.8A CN102520113B (en) 2011-12-16 2011-12-16 Detection method for fifteen Rupeng preparation

Publications (2)

Publication Number Publication Date
CN102520113A CN102520113A (en) 2012-06-27
CN102520113B true CN102520113B (en) 2014-05-07

Family

ID=46291101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110427293.8A Active CN102520113B (en) 2011-12-16 2011-12-16 Detection method for fifteen Rupeng preparation

Country Status (1)

Country Link
CN (1) CN102520113B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104042824B (en) * 2014-06-26 2017-05-10 长春人民药业集团有限公司 Preparation and detecting methods of traditional Chinese medicine composition for treating wind-cold-wetness evil
CN107860859B (en) * 2017-09-15 2020-07-10 杭州富纯实业有限公司 Method for determining ten-ingredient Daoxiangwan as Tibetan medicine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586598A (en) * 2004-07-26 2005-03-02 黑龙江省完达山制药厂 Wuqi fat regulation oral liquid
CN1857620A (en) * 2006-04-06 2006-11-08 贵州同济堂制药有限公司 Quality control method for visual fatigue treating medicine preparation
CN101502628A (en) * 2009-01-14 2009-08-12 甘肃奇正藏药有限公司 Tibetan medicine pill for influenza as well as quality criteria and inspection method of preparation thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2732259B2 (en) * 1988-09-10 1998-03-25 三和生薬株式会社 New aconitine compounds and analgesic / anti-inflammatory agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586598A (en) * 2004-07-26 2005-03-02 黑龙江省完达山制药厂 Wuqi fat regulation oral liquid
CN1857620A (en) * 2006-04-06 2006-11-08 贵州同济堂制药有限公司 Quality control method for visual fatigue treating medicine preparation
CN101502628A (en) * 2009-01-14 2009-08-12 甘肃奇正藏药有限公司 Tibetan medicine pill for influenza as well as quality criteria and inspection method of preparation thereof

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
B. Polak et al..Effect of acidic mobile phase additives on the TLC behaviour of some alkaloids.《ACTA CHROMATOGRAPHICA》.2007,(第18期),24-18.
Effect of acidic mobile phase additives on the TLC behaviour of some alkaloids;B. Polak et al.;《ACTA CHROMATOGRAPHICA》;20071231(第18期);24-18 *
RP-HPLC测定十五味乳鹏胶囊中酯型生物碱的含量;易进海等;《中成药》;20010825;第24卷(第8期);第587左栏第1段 *
Separation and determination of aconitine alkaloids in traditional Chinese herbs by nonaqueous capillary electrophoresis;Yuqin Li et al.;《ELECTROPHORESIS》;20040930;第25卷(第17期);3003-3009 *
Yuqin Li et al..Separation and determination of aconitine alkaloids in traditional Chinese herbs by nonaqueous capillary electrophoresis.《ELECTROPHORESIS》.2004,第25卷(第17期),3003-3009.
关于《中国药典》中乌头碱限量检查法改进;王晓晖等;《中国现代中药》;20061216;第8卷(第12期);第12页左栏第4,8段,图1、2 *
参三七伤药片质量标准研究;姚海燕等;《医药导报 》;20101201;第29卷(第12期);1641-1643 *
姚海燕等.参三七伤药片质量标准研究.《医药导报 》.2010,第29卷(第12期),1641-1643.
易进海等.RP-HPLC测定十五味乳鹏胶囊中酯型生物碱的含量.《中成药》.2001,第24卷(第8期),第587左栏第1段.
李文军等.藏药然降多吉胶囊质量标准研究.《成都中医药大学学报》.2001,第24卷(第2期),35-37.
杨凤梅等.流感丸的定性定量分析方法研究.《中成药》.2008,第30卷(第4期),543-547.
流感丸的定性定量分析方法研究;杨凤梅等;《中成药》;20080420;第30卷(第4期);543-547 *
王晓晖等.关于《中国药典》中乌头碱限量检查法改进.《中国现代中药》.2006,第8卷(第12期),第12页左栏第4,8段,图1、2.
藏药然降多吉胶囊质量标准研究;李文军等;《成都中医药大学学报》;20010628;第24卷(第2期);35-37 *
陈志娟等.降脂冲剂中何首乌与决明子的薄层鉴别.《天津中医药》.2008,第25卷(第2期),第159页右栏第1段.
降脂冲剂中何首乌与决明子的薄层鉴别;陈志娟等;《天津中医药》;20080412;第25卷(第2期);第159页右栏第1段 *

Also Published As

Publication number Publication date
CN102520113A (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN100536870C (en) Qulity control method for new compound isatis leaf preparation
CN107991425B (en) Detection method of traditional Chinese medicine composition for treating traumatic injury
CN106198837A (en) The quality determining method of old cough with asthma sheet
CN101987121B (en) Detection method of medicine composition for treating hepatitis
CN102120021B (en) Detection method of concentrated pills for treating hyperplastic disease of breast
CN107028994A (en) The direct oral traditional Chinese medicine medicine materical crude slice of Radix Notoginseng powder
CN1981852B (en) Tall gastrodia tuber preparation with resuscitation-inducing function, its making and quality controlling method
CN106370756B (en) A kind of detection method of Chinese materia medica preparation that preventing and treating infectious bronchitis of chicken
CN102419357B (en) Method for detecting eighteen-component codonopsis pilosula preparation
CN102091168A (en) Quality control method for Chinese medicine preparation Xuefuzhuyu capsule
CN102520113B (en) Detection method for fifteen Rupeng preparation
CN102038795B (en) Detection method of five-nut demulcent pill as traditional Chinese medical preparation
CN107252465B (en) Analysis method of traditional Chinese medicine composition for regulating allergic constitution
CN102608249B (en) Detection method of Tenghuang Jiangu pill
Garg et al. Fingerprint profile of selected ayurvedic churnas/preparations: An overview
CN107184661A (en) The direct oral traditional Chinese medicine medicine materical crude slice of vinegar tetrahydropalmatine
CN102520110B (en) Method for detecting ten-flavour rankincense preparation
CN1970035B (en) Formulation of &#39;Sheng Mai&#39;, preparation process and quality control method thereof
CN100585401C (en) Detection method for orally administered formulation for reducing fat and expelling toxins
CN103033585A (en) Method for detecting medicaments for treating mammitis and hyperplasia of mammary glands
CN100570358C (en) Treat the detection method of asthenopic pharmaceutical preparation
CN106420632B (en) A medicinal granule for treating gynecological diseases, and its preparation method
CN101632804B (en) Quality control method for wind-dispelling heat-dissipating capsules
CN108535399A (en) A kind of detection method of Fuyankang pill
CN107158090A (en) The direct oral traditional Chinese medicine medicine materical crude slice of decumbent corydalis tuber powder

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant